titanium dioxide has been researched along with sirolimus in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Desai, TA; Grimes, CA; LaTempa, TJ; Mendelsohn, AD; Peng, L; Yoriya, S | 1 |
| Chen, X; Huo, Y; Li, H; Li, W; Li, Z; Lu, C; Lu, Q; Lyu, S; Song, X; Wang, D; Wang, L; Xu, B; Yuan, F; Zhang, Z | 1 |
| Li, Z; Yang, Z; Yin, H; Zhang, T; Zhang, X | 1 |
1 trial(s) available for titanium dioxide and sirolimus
| Article | Year |
|---|---|
Novel completed biodegradable polymer sirolimus-eluting stent versus durable polymer sirolimus-eluting stent in de novo lesions: nine-month angiographic and three-year clinical outcomes of HOPE trial.
Topics: Adult; Aged; Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Humans; Middle Aged; Percutaneous Coronary Intervention; Polymers; Sirolimus; Titanium; Treatment Outcome; Young Adult | 2014 |
2 other study(ies) available for titanium dioxide and sirolimus
| Article | Year |
|---|---|
Long-term small molecule and protein elution from TiO2 nanotubes.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Proliferation; Drug Implants; Mice; Nanotubes; Paclitaxel; Pharmaceutical Preparations; Proteins; Serum Albumin, Bovine; Sirolimus; Titanium | 2009 |
Nano-TiO
Topics: Adenine; AMP-Activated Protein Kinases; Animals; Antioxidants; Apoptosis; Autophagy; Cell Line; Cell Proliferation; Cytoprotection; Enzyme Activation; Mice; Nanoparticles; Oxidative Stress; Podocytes; Signal Transduction; Sirolimus; Titanium; TOR Serine-Threonine Kinases | 2016 |